featured
Effects of Extended-Interval Dosing of Natalizumab and Drug Concentrations on Brain Atrophy in Patients With MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis
Mult. Scler. 2024 Jan 18;[EPub Ahead of Print], AA Toorop, S Noteboom, MD Steenwijk, JW Gravendeel, B Jasperse, F Barkhof, EM Strijbis, T Rispens, MM Schoonheim, ZL van Kempen, J KillesteinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.